跳至主要内容
临床试验/CTRI/2024/08/072930
CTRI/2024/08/072930尚未招募4 期

Effectiveness and safety of Carbetocin vs Prostadin in patients with high risk of postpartum hemorrhage undergoing caesarean section - A Randomised control trial.

Dr Rangarajan memorial hospital/ Sundaram Medical Foundation1 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2024年8月28日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
59
试验地点
1
主要终点
Need for additional uterotonics and blood transfusion

研究概览

简要总结

To assess the effectiveness of Carbetocin vs Prostadin in patients with high risk of postpartum hemorrhage in patients undergoing cesarean section by assessing the need for any further uterotonics or blood transfusion in first 24 hours post LSCS.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Investigator Blinded

入排标准

年龄范围
19.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • Prolonged labour Multiple pregnancies Obesity Anemia Macrosomia.

排除标准

  • Normal delivery Hypersensitivity to drugs Bronchial asthma.

结局指标

主要结局

Need for additional uterotonics and blood transfusion

时间窗: 24 hours at baseline

次要结局

  • Not applicable(Not applicable)

研究者

发起方
Dr Rangarajan memorial hospital/ Sundaram Medical Foundation
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

DR VISHRUTHA SRI S

Dr rangarajan memorial hospital; Sundaram Medical Foundation

研究点 (1)

Loading locations...

相似试验

Carbetocin vs Prostadin in patients- Best drug for... | 临床试验